OpenAI Acquires Biotech Startup, AI Competes in the Drug Development Field
2026-10-21 01:57:48
According to CoinMeta, as reported by Axios, OpenAI recently acquired a biotech startup, marking that the artificial intelligence competition is gradually entering the field of drug development. This acquisition will further promote the application and development of AI in the healthcare sector.
Source:X
This content is for market information only and does not constitute investment advice.
Follow HKWDB official accounts to stay updated

Hot Articles
Refresh

US Memory Chip Stocks Surge: Can SanDisk's $70B Rally Last?
15h ago

How to Get US Stock News in China? 4 Free Channels
10-16 19:24

What Is a Bitcoin ETF? $104.8B AUM, 6.38% Market Cap Explained
10-15 17:03

Microsoft Stock: $551, $2.5 From High, Breakout or Pullback?
10-14 14:56

Top 5 Crypto Exchanges 2026: Security & Fees Compared
10-13 12:47



